Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,098,321 papers from all fields of science
Search
Sign In
Create Free Account
pecilocin
Known as:
1-(8-hydroxy-6-methyl-1-oxo-2,4,6- dodecatrienyl)-2-pyrrolidinone
, 1-[(2E,4E,6E,8R)-8-hydroxy-6-methyldodeca-2,4,6-trienoyl]pyrrolidin-2-one
An antifungal agent isolated from Paecilomyces varioti Bainier var. antibioticus with topical activity against common dermatophytes.
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
Broader (1)
Pyrrolidinones
Narrower (1)
Variotin
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2001
2001
Method for cultivating variotin pecilocin with silkworm and medicinal use
徐哲
,
徐道田
,
苑桂华
,
唐国镇
,
金顺姬
,
王波
2001
Corpus ID: 90885482
By using silkworm as host and through the technological processes of strain preparation, strain culture, silkworm selection…
Expand
1977
1977
[Pecilocin allergy].
O. Nørgaard
Der Hautarzt; Zeitschrift fur Dermatologie…
1977
Corpus ID: 10973239
In 1975 there were a total of 44 patients in the author's practice with a history of treatment with pecilocinum (Variotin). These…
Expand
Review
1976
Review
1976
[Antimycotic antibiotics (author's transl)].
A. van Miert
,
J. V. van Soeren
,
F. M. Hagens
Tijdschrift voor diergeneeskunde
1976
Corpus ID: 31199029
A number of antibiotics having an antimycotic action are reviewed. The physicochemical and pharmacotoxicological properties…
Expand
1969
1969
A Comparative Trial of Chlorphenesin and Pecilocin in a Prison Community
C. Harris
,
C. Philpot
The British journal of clinical practice
1969
Corpus ID: 46576879
. In Maidstone Prison, ringworm of the feet has been clinically endemic for a number of years. This observation accords with…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE